Categorynews

13 of Top 20 Pharma Companies Adopt Veeva CRM Events Management for Better and More Compliant Events

April 17, 2019 Off By BusinessWire

Organizations are driving deeper customer insights with end-to-end
events management solution seamlessly integrated with CRM

BARCELONA, Spain–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/lifesciences?src=hash" target="_blank"gt;#lifescienceslt;/agt;–Veeva
Systems (NYSE:VEEV) today announced that top life sciences companies
are adopting Veeva
CRM Events Management to manage their customer events. More than 60
companies, including 13 of the top 20 pharmaceutical companies, are
using Veeva CRM Events Management in at least one region to run fully
integrated events for improved engagement with healthcare professionals
(HCPs) and greater visibility across all events.

Nearly 72% of life sciences organizations report that using disparate
systems is their biggest challenge in managing events.¹ Veeva
CRM Events Management streamlines the management of events in a single
system, providing a holistic approach to plan and execute all events and
activities.

For example, global biopharmaceutical company, Bristol-Myers Squibb,
successfully implemented Veeva CRM Events Management in more than 58
markets to improve the efficiency and compliance of their events
worldwide.

“By streamlining events planning globally with Veeva CRM Events
Management, we have standardized critical components of our programs,
which in turn has significantly reduced the time to execute events,”
said Lynn Kubinski, head of HCP interactions, congress, and meetings
management at Bristol-Myers Squibb. “Also, our teams have insight into
what worked and what could be done better next time. Ultimately, this
enhances our engagement with customers.”

Veeva CRM Events Management is seamlessly integrated with multichannel Veeva
CRM to easily track speakers, spend, and attendees globally. This
allows organizations to incorporate events as part of their multichannel
strategy and better coordinate HCP engagement.

With a comprehensive network of 15 partners, customers also have access
to integrated, specialized products and services such as speaker and
venue management, logistics services, and compliance systems to use with
Veeva CRM Events Management. Veeva’s extensive ecosystem of partners
gives customers more choice in how they execute events.

“Events are one of the most effective and efficient ways for commercial
and medical affairs teams to engage more healthcare professionals,” said
David Logue, senior vice president of commercial strategy at Veeva
Systems. “Veeva CRM Events Management gives the industry an end-to-end
solution fully integrated with Veeva CRM to efficiently and compliantly
manage events and improve customer engagement.”

Registrations for Veeva
Commercial & Medical Summit Europe are now open. Join us in
Barcelona from 3-5 December 2019, where more than 1,200 life sciences
professionals will gather to hear the latest news and market trends in
the industry, experience innovative technology, and network and share
best practices.

Additional Information
For more on Veeva CRM Events
Management, visit: veeva.com/eu/EventsManagement
Connect
with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veeva_eu on Twitter: twitter.com/veeva_EU
Like
Veeva on Facebook: facebook.com/veevasystems

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.

Forward-looking Statements

This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2019. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.